Cell Signaling Technology

beta-Amyloid (1-40) (D8Q7I) Horse Chimeric Monoclonal Antibody

#77438 · $160

1
Citing papers
29
Combined citations
Supplier page Find this product

Research areas

Cancer Treatment and Pharmacology1Colorectal Cancer Treatments and Studies1Peptidase Inhibition and Analysis1

Papers citing this product

1
TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer
Aging·2022·29 cit.·DOI

Similar products

ProductVendorPricePapers
beta-Amyloid (1-40) (D8Q7I) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology$160100
beta-Amyloid (1-40) (D8Q7I) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$8653
beta-Amyloid (1-40) (D8Q7I) Feline Chimeric Monoclonal AntibodyFeline chimericCell Signaling Technology$160—
beta-Amyloid (1-40) (D8Q7I) Mouse Chimeric Monoclonal AntibodyMouse chimericCell Signaling Technology$160—
beta-Amyloid (1-40) (D8Q7I) Horse Chimeric Monoclonal Antibody — Evidence — PubIndex